Choose topic

Latest News in the pharma Industry

Research & Development

Near-Atomic Resolution of Protein Structure by Electron Microscopy Holds Promise for Drug Discovery

8 May 2015

Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference

5 May 2015

NIH Summit Delivers Recommendations to Transform Alzheimer’s Disease Research

4 May 2015

Luspatercept Data Presented at the 13th International Symposium on Myelodysplastic Syndromes

4 May 2015

Amgen Discusses Details of the BLA for Talimogene Laherparepvec for Patients with Metastatic Melanoma

30 Apr 2015

GSK Candidate Vaccine for the Prevention of Shingles Demonstrates Overall Efficacy of 97.2%

29 Apr 2015

IDT Opens Molecular Biology R&D Facility in Redwood City

28 Apr 2015

Synthon Announces Successful Outcomes from the Open-label Extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

28 Apr 2015

Merck Announces Publication of Pivotal Data from Phase III Clinical Studies of Zerbaxa

28 Apr 2015

AMSBIO has Launched a New and Exclusive Biotinylated Protein Collection

28 Apr 2015

MSD Announces Results from its Pivotal Phase III C-EDGE Programme and C-SURFER Trial

27 Apr 2015

Janssen Announces Phase III OPTIMIST Data

27 Apr 2015

Are you a supplier

Here's what we can do for you

Generate quality leads for your business

Stay visible for 365 days of the year

Receive product inquiries and respond to meeting requests directly

Improve company online presence through Search Engine Optimisation

Latest News in the pharma Industry

Research & Development

Near-Atomic Resolution of Protein Structure by Electron Microscopy Holds Promise for Drug Discovery

Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference

NIH Summit Delivers Recommendations to Transform Alzheimer’s Disease Research

Luspatercept Data Presented at the 13th International Symposium on Myelodysplastic Syndromes

Amgen Discusses Details of the BLA for Talimogene Laherparepvec for Patients with Metastatic Melanoma

GSK Candidate Vaccine for the Prevention of Shingles Demonstrates Overall Efficacy of 97.2%

IDT Opens Molecular Biology R&D Facility in Redwood City

Synthon Announces Successful Outcomes from the Open-label Extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

Merck Announces Publication of Pivotal Data from Phase III Clinical Studies of Zerbaxa

AMSBIO has Launched a New and Exclusive Biotinylated Protein Collection

MSD Announces Results from its Pivotal Phase III C-EDGE Programme and C-SURFER Trial

Janssen Announces Phase III OPTIMIST Data

Are you a supplier

Here's what we can do for you

Login